Oxford Metrics PLC
09 October 2026
9 October 2026
Oxford Metrics plc
(“OxfordMetrics” or the “Group”)
Acquisition of Move AI assets
Expands Vicon’s markerless motion capture capabilities
Oxford Metrics plc (LSE: OMG), the smart sensing and measurement technology group serving life sciences, entertainment, engineering and manufacturing markets, announces that, following a competitive bid process, it has acquired the assets of Move AI Ltd (“Move AI” the “Acquisition”), a London-based developer of AI-powered technology for capturing and digitising human movement. The Acquisition is intended to accelerate Vicon’s markerless motion capture strategy by broadening its technology, customer reach and range of applications. Move AI’s technology, intellectual property, patents, specialist team and customers will transfer to Vicon, the Group’s motion capture division, as part of the transaction.
Move AI combines artificial intelligence, computer vision and an understanding of human biomechanics to convert video into detailed 3D motion data without the need for markers or specialist suits. Following significant investment in product development, it has developed technology that spans single-camera tools for individual creators through to professional multi-camera and real-time systems, including its flagship Genesis platform. It enables capture inside and outside the studio, from individual performances to multiple people moving across spaces as large as a football pitch.
The Acquisition is expected to be highly complementary to Vicon and enhances its existing capabilities. Combining Move AI’s technology with Vicon’s measurement expertise and global customer relationships is expected to accelerate product development and make sophisticated motion capture accessible to a broader range of users. The Board also believe it is complementary to the wider Group’s offering in entertainment and content creation by increasing opportunities for wider applications in sport, biomechanics and human performance analysis.
The Acquisition follows Vicon’s acquisition of Captive Devices in September 2026, which added markerless facial capture to its existing body-tracking capabilities. Move AI further broadens Vicon’s markerless toolset through complementary single-camera and large-volume capture technologies, creating a more comprehensive end-to-end solution across facial, body and full-environment motion capture. Together with Move AI these capabilities strengthen Vicon's position in next-generation motion capture and provide customers with greater flexibility to combine markerless workflows with its industry-leading optical systems.
Consideration for the Acquisition is £525,000 in cash (c.£725,000 inclusive of immediate transaction expenses). Move.ai reported unaudited revenue of £1.1 million in the year ended 31 December 2025 and gross margin in line with Vicon's strong levels.
Gary Bullard, Non-Executive Chair and Interim CEO of Oxford Metrics, commented:“This acquisition is closely aligned with our strategy to broaden Vicon’s markerless capabilities while maintaining its leadership in optical motion capture. Through our own technology development and recent acquisitions, Vicon has built a comprehensive toolset spanning marker-based and markerless motion capture. Move AI further strengthens that offering, enabling us to address a wider range of customer applications, introduce additional capabilities across our combined customer base and create opportunities in new markets.”
For more information, please contact:
|
Oxford Metrics plc Gary Bullard, Non-Executive Chair (and interim CEO) Zoe Fox, CFO
|
+44 (0) 18 6526 1860 |
|
Panmure Liberum (Nomad and Broker)
James Sinclair-Ford / Rupert Dearden
|
+44 (0) 20 3100 2000 |
|
Alma Strategic Communications Hilary Buchanan / David Ison / Louisa El-Ahwal |
+44 (0) 20 3405 0205 |
About Oxford Metrics
Oxford Metrics (LSE:OMG) is a smart sensing and measurement technology Group that serves thousands of customers in more than 70 countries. Founded in 1984, we started our journey in healthcare, expanded into entertainment, winning an OSCAR® and an Emmy®, moved into engineering and more recently, manufacturing. We have a strong track record of creating value by incubating, growing and then augmenting through acquisition, unique technology businesses.
The Group trades through two divisions: in motion capture its market-leading company Vicon Motion Systems provides motion measurement analysis to thousands of customers worldwide in healthcare, entertainment and engineering markets. In vision metrology, Industrial Vision and Metrology Systems is a specialist in machine vision software and measurement providing high precision, automated quality control systems trusted by blue-chip manufacturing companies in medical devices, pharmaceuticals, aerospace, automotive and precision engineering markets.
The Group is headquartered in Oxford with offices in the United Kingdom, Ireland, United States and Germany. Since 2001, Oxford Metrics (LSE: OMG) has been a quoted company listed on AIM, a market operated by the London Stock Exchange.
For more information about Oxford Metrics, visit www.oxfordmetrics.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.